Urinary C-Peptide Creatinine Ratio as a Non-Invasive Tool for Identifying Latent Autoimmune Diabetes in Adults (LADA)

References

• Buzzetti R , Di Pietro S , Giaccari A , et al.; Non Insulin Requiring Autoimmune Diabetes Study Group. High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes. Diabetes Care . 2007;30(4):932–938. doi:10.2337/dc06-1696 17392553
   PubMed Web of Science ®Google Scholar
• Yang L , Zhou ZG , Huang G , et al. Six-year follow-up of pancreatic beta cell function in adults with latent autoimmune diabetes. World J Gastroenterol . 2005;11(19):2900–2905. doi:10.3748/wjg.v11.i19.2900 15902725
   PubMed Web of Science ®Google Scholar
• Andersen CD , Bennet L , Nyström L , et al. Worse glycaemic control in LADA patients than in those with type 2 diabetes, despite a longer time on insulin therapy. Diabetologia . 2013;56(2):252–258. doi:10.1007/s00125-012-2759-y 23096095
   PubMed Web of Science ®Google Scholar
• Thunander M , Thorgeirsson H , Törn C , et al. β-cell function and metabolic control in latent autoimmune diabetes in adults with early insulin versus conventional treatment: a 3-year follow-up. Eur J Endocrinol . 2011;164(2):239–245. doi:10.1530/EJE-10-0901 21088056
   PubMed Web of Science ®Google Scholar
• Buzzetti R , Zampetti S , Maddaloni E . Adult-onset autoimmune diabetes: current knowledge and implications for management. Nat Rev Endocrinol . 2017;13(11):674–686. doi:10.1038/nrendo.2017.99 28885622
   PubMed Web of Science ®Google Scholar
• Mishra R , Hodge KM , Cousminer DL , et al. A global perspective of latent autoimmune diabetes in adults. Trends Endocrinol Metab . 2018;29(9):638–650. doi:10.1016/j.tem.2018.07.001 30041834
   PubMed Web of Science ®Google Scholar
• Jones AG , Hattersley AT . The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabet Med . 2013;30(7):803–817. doi:10.1111/dme.12159 23413806
   PubMed Web of Science ®Google Scholar
• McDonald TJ , Knight BA , Shields BM , et al. Stability and reproducibility of a single-sample urinary C-peptide/creatinine ratio and its correlation with 24-h urinary C-peptide. Clin Chem . 2009;55(11):2035–2039. doi:10.1373/clinchem.2009.129312 19713273
   PubMed Web of Science ®Google Scholar
• Palmer JP , Fleming GA , Greenbaum CJ , et al. C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21–22 October 2001. Diabetes . 2004;53(1):250–264. doi:10.2337/diabetes.53.1.250 14693724
   PubMedGoogle Scholar
• Besser RE , Ludvigsson J , Jones AG , et al. Urine C-peptide creatinine ratio is a noninvasive alternative to the mixed-meal tolerance test in children and adults with type 1 diabetes. Diabetes Care . 2011;34(3):607–609. doi:10.2337/dc10-2114 21285386
   PubMed Web of Science ®Google Scholar
• Besser RE , Shields BM , Hammersley SE , et al. Home urine C-peptide creatinine ratio (UCPCR) testing can identify type 2 and MODY in pediatric diabetes. Pediatr Diabetes . 2013;14(3):181–188. doi:10.1111/pedi.12008 23289766
   PubMed Web of Science ®Google Scholar
• Hope SV , Jones AG , Goodchild E , et al. Urinary C-peptide creatinine ratio detects absolute insulin deficiency in type 2 diabetes. Diabet Med . 2013;30(11):1342–1348. doi:10.1111/dme.12222 23659458
   PubMed Web of Science ®Google Scholar
• Alberti KG , Zimmet PZ . Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med . 1998;15(7):539–553. doi:10.1002/(ISSN)1096-9136 9686693
   PubMed Web of Science ®Google Scholar
• Mishra R , Chesi A , Cousminer DL , et al. Relative contribution of type 1 and type 2 diabetes loci to the genetic etiology of adult-onset, non-insulin-requiring autoimmune diabetes. BMC Med . 2017;15(1):88. doi:10.1186/s12916-017-0846-0 28438156
   PubMed Web of Science ®Google Scholar
• Deng C , Xiang Y , Tan T , et al. Altered peripheral B-lymphocyte subsets in type 1 diabetes and latent autoimmune diabetes in adults. Diabetes Care . 2016;39(3):434–440. doi:10.2337/dc15-1765 26721817
   PubMed Web of Science ®Google Scholar
• Johansen OE , Boehm BO , Grill V , et al. C-peptide levels in latent autoimmune diabetes in adults treated with linagliptin versus glimepiride: exploratory results from a 2-year double-blind, randomized, controlled study. Diabetes Care . 2014;37(1):e11–e12. doi:10.2337/dc13-1523 24356601
   PubMed Web of Science ®Google Scholar
• Buzzetti R , Pozzilli P , Frederich R , et al. Saxagliptin improves glycaemic control and C-peptide secretion in latent autoimmune diabetes in adults (LADA). Diabetes Metab Res Rev . 2016;32(3):289–296. doi:10.1002/dmrr.2717 26385269
   PubMed Web of Science ®Google Scholar
• Brophy S , Davies H , Mannan S , et al. Interventions for latent autoimmune diabetes (LADA) in adults. Cochrane Database Syst Rev . 2011;9:CD006165. doi:10.1002/14651858.CD006165.pub3
   Web of Science ®Google Scholar
• Hjort R , Ahlqvist E , Carlsson PO , et al. Overweight, obesity and the risk of LADA: results from a Swedish case-control study and the Norwegian HUNT Study. Diabetologia . 2018;61(6):1333–1343. doi:10.1007/s00125-018-4596-0 29589073
   PubMed Web of Science ®Google Scholar
• Lu J , Hou X , Pang C , et al. Pancreatic volume is reduced in patients with latent autoimmune diabetes in adults. Diabetes Metab Res Rev . 2016;32(8):858–866. doi:10.1002/dmrr.2806 27037998
   PubMed Web of Science ®Google Scholar
• Besser RE , Shepherd MH , McDonald TJ , et al. Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-{alpha}/hepatocyte nuclear factor 4-α maturity-onset diabetes of the young from long-duration type 1 diabetes. Diabetes Care . 2011;34(2):286–291. doi:10.2337/dc10-1293 21270186
   PubMed Web of Science ®Google Scholar
• Yılmaz Agladioglu S , Sagsak E , Aycan Z . urinary c-peptide/creatinine ratio can distinguish maturity-onset diabetes of the young from type 1 diabetes in children and adolescents: a single-center experience. Horm Res Paediatr . 2015;84(1):54–61. doi:10.1159/000375410 25792383
   PubMed Web of Science ®Google Scholar
• Liao Y , Xiang Y , Zhou Z . Diagnostic criteria of latent autoimmune diabetes in adults (LADA): a review and reflection. Front Med . 2012;6(3):243–247. doi:10.1007/s11684-012-0201-y 22843304
   PubMedGoogle Scholar
• Weber P , Ambrosova P , Canov P , et al. GAD antibodies in T1D and LADA-relations to age, BMI, c-peptide, IA-2 and HLA-DRB1*03 and DRB1*04 alleles. Adv Gerontol . 2011;24(2):312–318.21957594
   PubMedGoogle Scholar
• Weber P , Meluzínová H , Kubesová H , et al. Type 1 diabetes and LADA – occurrence of HLA-DRB1*03 and DRB1*04 alleles in two age different groups of diabetics. Adv Gerontol . 2009;23(2):243–248.
   Google Scholar
• Shields BM , McDonald TJ , Oram R , et al.; TIGI Consortium. C-Peptide decline in type 1 diabetes has two phases: an initial exponential fall and a subsequent stable phase. Diabetes Care . 2018;41(7):1486–1492. doi:10.2337/dc18-0465 29880650
   PubMed Web of Science ®Google Scholar
• Shields BM , Shepherd M , Hudson M , et al.; UNITED study team. Population-based assessment of a biomarker-based screening pathway to aid diagnosis of monogenic diabetes in young-onset patients. Diabetes Care . 2017;40(8):1017–1025. doi:10.2337/dc17-0224 28701371
   PubMed Web of Science ®Google Scholar
• Oram RA , Jones AG , Besser RE , et al. The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells. Diabetologia . 2014;57(1):187–191. doi:10.1007/s00125-013-3067-x 24121625
   PubMed Web of Science ®Google Scholar
• Maddaloni E , Lessan N , Al Tikriti A , et al. Latent autoimmune diabetes in adults in the United Arab Emirates: clinical features and factors related to insulin-requirement. PLoS One . 2015;10(8):e0131837. doi:10.1371/journal.pone.0131837 26252955
   PubMed Web of Science ®Google Scholar
• Zampetti S , Campagna G , Tiberti C , et al. High GADA titer increases the risk of insulin requirement in LADA patients: a 7-year follow-up (NIRAD study 7). Eur J Endocrinol . 2014;171(6):697–704. doi:10.1530/EJE-14-0342 25213702
   PubMed Web of Science ®Google Scholar